|
FY2022
12 months to Dec 31, 2022
|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net loss | ||
| Adjustments to reconcile net profit/(loss) to net cash used in operating activities: | ||
| Dividend earned from Trust Account | ||
| Change in fair value of over-allotment liability | ||
| Stock-based compensation | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses - current | ||
| Prepaid expenses - non-current | ||
| Accrued expenses | ||
| Related party payable | ||
| Income tax payable | ||
| Franchise tax payable | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Transfer from Trust Account | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of common stock to Sponsor | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Warrants | ||
| Proceeds from issuance of EBC Founder Shares | ||
| Proceeds from promissory note - related party | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net change in cash: | ||
| Cash - Beginning | ||
| Cash - Ending | ||
| Supplemental disclosure of non-cash financing activities: | ||
| Deferred offering costs included in accrued expenses | ||
| Deferred offering costs paid through promissory note - related party | ||
| Initial classification of over-allotment liability | ||
| Deferred underwriting commission | ||
| Remeasurement of common stock subject to redemption to redemption value |
Loading...